©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Inactivation of Chloramphenicol by O-Phosphorylation
A NOVEL RESISTANCE MECHANISM IN STREPTOMYCES VENEZUELAE ISP5230, A CHLORAMPHENICOL PRODUCER (*)

(Received for publication, April 25, 1995; and in revised form, September 6, 1995)

Roy H. Mosher (1)(§) Dominic J. Camp (2) Keqian Yang (1) M. Peter Brown (1) William V. Shaw (2)(¶) Leo C. Vining (1)(**)

From the  (1)Biology Department, Dalhousie University, Halifax, Nova Scotia, B3H 4J1 Canada and the (2)Department of Biochemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Plasmid pJV4, containing a 2.4-kilobase pair insert of genomic DNA from the chloramphenicol (Cm) producer Streptomyces venezuelae ISP5230, confers resistance when introduced by transformation into the Cm-sensitive host Streptomyces lividans M252 (Mosher, R. H. Ranade, N. P., Schrempf, H., and Vining, L. C.(1990) J. Gen. Microbiol. 136, 293-301). Transformants rapidly metabolized Cm to one major product, which was isolated and purified by reversed phase chromatography. The metabolite was identified by nuclear magnetic resonance spectroscopy and mass spectrometry as 3`-O-phospho-Cm, and was shown to have negligible inhibitory activity against Cm-sensitive Micrococcus luteus. The nucleotide sequence of the S. venezuelae DNA insert in pJV4 contains an open reading frame (ORF) that encodes a polypeptide (19 kDa) with a consensus motif at its NH(2) terminus corresponding to a nucleotide-binding amino acid sequence (motif A or P-loop; Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J.(1982) EMBO J. 1, 945-951). When a recombinant vector containing this ORF as a 1.6-kilobase pair SmaI-SmaI fragment was used to transform S. lividans M252, uniformly Cm-resistant transformants were obtained. A strain of S. lividans transformed by a vector in which the ORF had been disrupted by an internal deletion yielded clones that were unable to phosphorylate Cm, and exhibited normal susceptibility to the antibiotic. The results implicate the product of the ORF from S. venezuelae as an enzymic effector of Cm resistance in the producing organism by 3`-O-phosphorylation. We suggest the trivial name chloramphenicol 3`-O-phosphotransferase for the enzyme.


INTRODUCTION

Chloramphenicol (Cm; Fig. 1), (^1)a broad-spectrum antibiotic that inhibits protein biosynthesis by binding reversibly to the peptidyl transferase center of 50 S ribosomal subunits (Pongs, 1979), is produced by Streptomyces venezuelae and some related species (Vining and Westlake, 1984). During growth under conditions where Cm is not produced, S. venezuelae is relatively sensitive to the antibiotic, but high-level resistance is induced by exposure to Cm; in cultures grown under Cm-producing conditions, resistance increases concurrently with Cm synthesis. However, ribosomes extracted from producing or nonproducing mycelium are equally sensitive to the antibiotic (Malik and Vining, 1970, 1972). Resistance to Cm is mediated in most eubacteria by chloramphenicol acetyltransferase (CAT; EC 2.3.1.28: reviewed by Shaw(1983) and Shaw and Leslie(1991)); this enzyme modifies Cm by acetylation, yielding 3`-O-acetyl-Cm, which is only very weakly bound by ribosomes and thus is not an antibiotic. Since S. venezuelae lacks CAT activity (Shaw and Hopwood, 1976; Nakano et al., 1977), alternative mechanisms have been sought to explain the ability of the producing organism to avoid inhibition by one of its own products (Vining and Westlake, 1984).


Figure 1: Structure of chloramphenicol and its derivatives.



By cloning genomic S. venezuelae DNA in the streptomycete vector pIJ702 and transforming the Cm-hypersensitive Streptomyces lividans M252 to resistance, Mosher and co-workers(1990) obtained a transformant (RM3) harboring a recombinant plasmid (pJV3) with a 6.5-kbp insert. Deletion from pJV3 of a 5.2-kbp segment (encompassing 4.1-kbp from the insert and 1.1-kbp from the pIJ702 vector) yielded pJV4, from which a region implicated in Cm resistance was subcloned as a 2.4-kbp KpnI-SstI fragment. Cultures of S. lividans RM3 rapidly metabolized [U-^14C]chloramphenicol to unidentified labeled products (Mosher et al., 1990).

We report here the isolation and characterization of the major product of Cm metabolism by S. lividans RM3 and RM4 (M252 transformed with pJV4). Identification of this metabolite as the 3`-phospho ester of Cm implicates a mechanism of Cm resistance for the producing organism that has not hitherto been encountered in streptomycetes or other microbial systems.


EXPERIMENTAL PROCEDURES

Materials

Restriction endonucleases and DNA modifying enzymes were obtained from Life Technologies, Inc., Promega, New England Biolabs, and Pharmacia Biotech Inc. Cm and D-threo-p-nitrophenylserinol (Cm-base) were from Sigma.

Bacteria, Plasmids, and Culture Conditions

The properties of S. lividans M252, and those of transformants RM3 (containing pJV3) and RM4 (containing pJV4) have been described (Mosher et al., 1990). Escherichia coli was grown in 2 times YT broth (10 g of yeast extract, 16 g of Bacto-tryptone and 5 g of NaCl per liter). Conditions for E. coli growth, transformation, transfection, and plasmid isolation were essentially as described by Sambrook et al.(1989). Batch cultures of S. lividans were grown in GNY medium (20 ml of glycerol, 8 g of nutrient broth, 3 g of yeast extract, and 5 g of K(2)HPO(4) per liter) for 48 h at 30 °C (Malik and Vining, 1970). Conditions for transforming Streptomyces and for plasmid isolation were as described (Hopwood et al., 1985). Table 1lists the strains and plasmids used in this work.



High Performance Liquid Chromatography (HPLC)

Culture broths and extracts were analyzed for Cm and its derivatives by HPLC on a 4.6 times 50-mm Phenomenex Ultracarb ODS-30 C(18) column (5-µm particle size). The column was initially equilibrated with 30 mM potassium phosphate buffer, pH 3.3. At the sample injection, a programmed methanol gradient was started: the methanol concentration increased linearly to 25, 50, and 100% at 1, 6, and 7 min, respectively, remained at 100% for 3 min, and then reduced to zero over 1 min. The column was re-equilibrated for 5 min before the next injection. Nitrophenyl derivatives were detected by their absorbance at 273 nm.

Isolation of 3`-Phospho-Cm from Suspensions of RM4 Mycelium

To investigate Cm metabolism by S. lividans RM3 and RM4, mycelium was grown in GNY medium supplemented with Cm at a final concentration of 12.5 µg/ml (38.7 µM). Cultures were routinely inoculated with spore suspensions and incubated at 30 °C on a rotary shaker (3.7-cm eccentricity; 250 rpm). Mycelial suspensions for converting Cm to 3`-phospho-Cm were prepared as follows; 250 ml of RM4 cells grown for 48 h were centrifuged (35,000 times g for 10 min at 4 °C), and washed aseptically with water. They were resuspended in 250 ml of water containing Cm (200 µg/ml), and incubated in a 1-liter Erlenmeyer flask for 23 h under the conditions used for growing cultures. The cells were then removed by centrifugation, and the supernatant was decanted and stored at -20 °C. The supernatant was concentrated to 1 ml at 40 °C in vacuo, and acidified with 100 µl of 1 M ammonium formate buffer, pH 2.5. The resulting solution, pH 3.4, was clarified by filtration and applied to a C(18) reversed-phase silica column (1 times 23 cm, 40-µm particle size, Bakerbond) packed in water. After 1 ml of 0.1 M ammonium formate buffer, pH 2.5, had been added, the products were eluted with water. Fractions were monitored by HPLC; those that contained Cm or 3`-phospho-Cm were pooled appropriately and concentrated in vacuo. By this procedure 3`-phospho-Cm greater than 99% pure by HPLC and NMR analysis, and free from contamination with Cm, was isolated in milligram quantities.

Nuclear Magnetic Resonance Spectrometry

The ^1H NMR spectra of samples were recorded in methanol at 250.1 MHz with tetramethylsilane as an internal reference; a Bruker AC-250 F spectrometer was used. Data was accumulated using 90° pulses (9.6 µs) with delays of 1 or 2 s; the data size was 16 K zero-filled to 32 K. The ^1H NMR spectrum for Cm contained signals at (ppm) 3.59 (q, 1H, H-3a` J 6.1 Hz, J 6.1 Hz), 3.81 (q, 1H, H-3b`, J 7.2 Hz, J 7.2 Hz), 4.13 (ct, 1H, H-2`, J 2.6 Hz, J 2.6 Hz, J 2.6 Hz), 5.15 (d, 1H, H-1`, J 2.5 Hz), 6.22 (s, 1H, CHCl(2)), and 7.89 (AA` BB`, 4H, H-2, H-3, H-5, H-6, consisting of doublets at 7.62 and 8.17 ppm, J = J = 8.9 Hz). The ^1H NMR spectrum of 3`-phospho-Cm contained signals at (ppm) 3.89 (m, 1H, H-3a`), 4.07 (m, 1H, H-3b`), 4.35 (m, 1H, H-2`), 5.22 (d, 1H, H-1`, J 3.5 Hz), 6.23 (s, 1H, CHCl(2)), and 7.92 (AA` BB`, 4H, H-2, H-3, H-5, H-6, consisting of doublets at 7.63 and 8.22 ppm, J 8.8 Hz, J 8.7 Hz).

The C NMR spectrum for Cm was recorded in acetone at 62.5 MHz using solvent C as a reference. Data were accumulated using 90° pulses (6 µs) with delays of 1 or 2 s. The data size was 32 K. The spectrum contained signals at (ppm) 58.5 (d, C-2`), 62.2 (t, C-3`), 67.4 (d, CHCl(2)), 71.3 (d, C-1`), 124.2 (d, C-2, C-6), 128.3 (d, C-3, C-5), 148.6 (s, C-1), 151.6 (s, C-4), and 166.6 (s, CO). The C NMR spectrum of 3`-phospho-Cm was recorded in D(2)O, locked to solvent deuterium; signals were present at (ppm) 58.3 (d, C-2`), 66.6 (t, C-3`), 68.7 (d, CHCl(2)), 73.3 (d, C-1`), 126.4 (d, C-2, C-6), 129.9 (d, C-3, C-5), 149.9 (s, C-1), 151.0 (s, C-4), and 169.6 (s, CO).

The P NMR spectrum of 3`-phospho-Cm was recorded at 101.2 MHz in D(2)O with 85% phosphoric acid as an external reference. Data were accumulated using 90° pulses (6 µs) with delays of 1 or 2 s. The data size was 32 K.

Mass Spectrometry

Mass spectra were obtained on an API/III triple quadrupole mass spectrometer (Perkin-Elmer SCIEX Instruments, Thornhill, Ontario) using nebulizer-assisted electrospray ionization (ion spray). The mass spectrum of 3`-phospho-Cm was acquired in the negative ion mode; 2 µl of a 7.5 µg/µl solution was injected into a stream of 50% acetonitrile (flow rate 10 µl/min). The mass spectrometer scanned over a mass range of 100-500 in steps of 0.1 Da, with a dwell time of 2 ms/step. The spectrometer was calibrated with a cesium nitrate standard; mass assignments were judged to be reliable to ±0.5 Da.

Antibiotic Assay

Assay disks (1.3-cm diameter) impregnated with aqueous solutions of Cm or 3`-phospho-Cm at known concentrations were placed on Difco nutrient agar seeded (2% v/v) with a 48-h nutrient broth culture of Micrococcus luteus. The relative antibiotic activities of the test samples were determined by measuring the diameters of inhibition zones around the disks after incubation overnight at 30 °C.

Construction and Use of Shuttle Vector pSV1.6

Standard procedures were used for manipulating DNA from Streptomyces spp. (Hopwood et al., 1985) and E. coli (Sambrook et al., 1989). DNA fragments from restriction digests separated by agarose gel electrophoresis were purified with a Geneclean kit (BIO-101); E. coli plasmids were purified with a Wizard miniprep kit (Promega). A 1.6-kbp fragment of the 2.4-kbp insert in pJV7 was produced by digesting the plasmid with SmaI. Cloning the purified fragment in pUC19 gave pDC1.6. To construct an E. coli/Streptomyces shuttle vector from pDC1.6, the plasmid was digested with HindIII and ligated to pIJ6017, also digested with HindIII. The ligation mixture was used to transform S. lividans M252; selection for transformants resistant to kanamycin and Cm (20 and 12.5 µg/ml, respectively) yielded pSV1.6.

Construction and Use of the ORF2/ORF3 Deletion Vector pDC-ORF1

To test whether ORF1 alone could confer Cm resistance, a 1-kbp fragment containing ORF2 and ORF3 was excised from pJV7. The plasmid was first linearized with BstEII, and the 3` overhang was filled in using the Klenow fragment of DNA polymerase I; digestion of the product with Acc65I furnished a 1.4-kbp fragment of insert DNA. Plasmid pJV4 was then digested with Acc65I and EcoICRI to recover the pIJ702-derived 4.7-kbp vector fragment free of the 2.4-kbp insert. The 1.4- and 4.7-kbp fragments were ligated, and the reaction product was used to transform S. lividans M252. From a transformant resistant to thiostrepton (20 µg/ml), plasmid pDC-ORF1 was isolated. Analysis of culture filtrates by HPLC showed that cells containing pDC-ORF1 were not able to convert Cm to 3`-phospho-Cm. No colonies were obtained when cells containing pDC-ORF1 were plated on solid media containing Cm (12.5 µg/ml).

Construction and Use of the Disrupted ORF2 Vector pJV11-DeltaSal

The SalI site in the polylinker region of pJV7 was removed by digesting the plasmid with HindIII and XbaI, followed by end-filling and religation. Digestion of the resulting plasmid pJV7a with SalI and religation yielded pJV7b in which the 363-bp SalI-SalI segment internal to ORF2 in the plasmid insert had been deleted. The modified insert was excised from pJV7b as a 2.0-kbp BamHI-SacI fragment, and recloned in pHJL400 linearized by digestion with BamHI and SacI, to give pJV11-DeltaSal. As a control, the intact insert from pJV7a was recloned in pHJL400 in the same way to give pJV11. Colonies obtained by transforming S. lividans M252 with pJV11 grew within 2 days of transfer to MYM agar containing 8 µg/ml Cm, whereas transformants containing pJV11-DeltaSal failed to grow within 5 days on this medium. Mycelium from the transformants grown for 48 h in GNY medium containing 5 µg/ml thiostrepton for plasmid maintenance was washed and resuspended in aqueous Cm (50 µg/ml). Analysis of the suspension at intervals by HPLC showed no conversion to 3`-phospho-Cm by mycelium from pJV11-DeltaSal transformants, whereas conversion occurred in control suspensions of mycelium carrying pJV11.

DNA Sequence and Sequence Analysis

For sequencing, the 2.4-kbp KpnI-SstI fragment of pJV4 was subcloned as smaller segments in the vectors M13 mp18, pTZ18R, and pBluescriptII SK+. Sets of overlapping nested deletions were prepared with exonuclease III and mung bean nuclease (Mosher, 1993). Single-stranded DNA, prepared either directly or by infection of a phagemid transformant with helper phage (VCSM13), was sequenced by the dideoxy chain termination method (Sanger et al., 1977) using a Sequenase version 2.0 kit (U. S. Biochemical Corp.). Both strands were sequenced, and ambiguous regions were resolved by using synthetic oligodeoxynucleotides (15-21-mers) derived from the generated sequence as sequencing primers, as well as by using deaza-dGTP or dITP in place of dGTP in the sequencing reactions.


RESULTS

Isolation of a Novel Cm Metabolite

Analysis by HPLC of filtrates from cultures grown in GNY medium with Cm at the highest concentration tolerated (12.5 µg/ml) revealed that S. lividans RM3 and RM4 rapidly converted the antibiotic to a single major extracellular product (Fig. 2) with an absorption maximum (273 nm) identical to that of Cm. In direct comparisons, the retention time of the Cm product (5.9 min) differed not only from that of Cm (6.3 min) but also from other related reference compounds, including 1`,3`-diacetyl-Cm (6.8 min), Cm-base (the free amine of Cm; 4.9 min), and N-acetyl-p-nitrophenylserinol (5.5 min).


Figure 2: Chromatographic analysis by HPLC of an aqueous Cm solution incubated 12 h with mycelium of S. lividans RM4.



Mycelium grown in a variety of media was active in converting Cm to its major metabolite; activity persisted in mycelium harvested after the end of the growth phase, or resuspended in water. Complete conversion was achieved by adding Cm at the concentration tolerated (12.5 µg/ml) to cultures of S. lividans RM4 growing in GNY medium. Furthermore, complete conversion was obtained by incubating washed mycelium with 200 µg/ml of Cm in water for 48 h. The use of aqueous cell suspensions simplified isolation of the metabolite, and facilitated its purification by reversed phase chromatography. The major chromatographic product was collected as a single sharp peak, well separated from other substances absorbing at 273 nm, and was evaporated to dryness at 40 °C in vacuo.

Identification of the Cm Metabolite

The ^1H NMR spectrum of the Cm metabolite was similar to that of Cm in that it contained signals consistent with the presence of a dichloroacetyl group and a 1,4-disubstituted phenylpropanoid derivative. However, it differed in the spin-spin coupling pattern of protons associated with the propanediol moiety. Whereas the H-3a` and H-3b` resonances for Cm were present as quartets due to coupling with each other and with H-2`, the resonances in the metabolite showed complex spin-spin coupling, and were displaced downfield with respect to those given by Cm. The data suggested that the propanediol protons of the metabolite were deshielded by an electron-withdrawing functional group probably attached at C-3`.

The C NMR spectrum of the metabolite was similar to that of Cm, with most of the signals slightly downfield of corresponding Cm signals. However, the signal assigned to C-3` showed a larger shift, from 62.2 to 66.6 ppm, consistent with the presence of an electron-withdrawing substituent on this carbon. That the latter is an orthophosphate group is supported by the P NMR spectrum of the product. The chemical shift (P, = 6.474 ppm) of the single strong signal was in the region of the spectrum predicted for an organophosphate ester (data not shown). Examination of the sample by low resolution, negative ion-spray mass spectrometry gave a group of molecular ions in the relative proportions expected for a substance containing two chlorine atoms (Fig. 3). The deduced M(r) of the compound is 401.97, the value predicted for a monophosphate ester of chloramphenicol. From the combined evidence, the most probable structure of the metabolite is, therefore, 3`-phospho-Cm.


Figure 3: Mass spectrum of the Cm metabolite obtained by negative ion spray. The deduced mass of the parent ion with Cl(2) was 401.9786.



To determine whether 3`-phospho-Cm exhibited antibiotic activity, the purified compound was compared with Cm in a disk-diffusion assay using M. luteus as the test organism. Inhibition zones were observed only with relatively large samples of 3`-phospho-Cm (>350 µg/disk), whereas 0.15 µg of Cm gave a measurable zone; in a standard assay, the apparent specific activity of 3`-phospho-Cm was 0.04% that of Cm. We conclude from this result that phosphorylation of the 3`-OH position of Cm reduces its antibiotic activity significantly.

Sequence and Analysis of the pJV4 Insert

The 2.4-kbp KpnI-SstI insert of S. venezuelae DNA cloned in pJV4 contained a 2355-bp nucleotide sequence (Fig. 4) with 73.6% G + C content. A sequence analysis (Fig. 5) of both strands for third position G + C bias, and for codon usage (Wright and Bibb, 1992), indicated one incomplete and three complete ORFs, the codon usage in which was typical of streptomycetes (Bibb et al., 1984).


Figure 4: The nucleotide and deduced amino acid sequences of the 2.4-kbp KpnI-SstI fragment of S. venezuelae ISP5230 DNA cloned in pJV4. Potential translational start and stop codons are overlined; plausible ribosome-binding sites are underlined, and inverted repeats have underlying facing arrows. The amino acid motifs for nucleotide binding are double underlined.




Figure 5: A, analysis of %G + C in the 2355-bp sequence of S. venezuelae DNA using the FRAME programme of Bibb et al.(1984) adapted for the Macintosh Plus microcomputer (Uchiyama and Weisblum, 1985; Doran et al., 1990). B, restriction enzyme sites on the cloned S. venezuelae DNA fragment (thick bar, same scale as A); the arrows immediately below represent the ORFs deduced from the FRAME analysis, and the location of translational start and stop codons. The short arrows show the sequencing strategy using both the exonuclease derived deletions and primers deduced from sequenced DNA.



Comparison of Derived Amino Acid (aa) Sequences with Data Base Sequences

ORF1

There are two possible ATG start sites for ORF1 (nt 28-30 and nt 100-102; see Fig. 4); the first gives a polypeptide 25 amino acids longer than the second. A FASTA sequence alignment (Pearson and Lipman, 1988) comparing ORF1 with sequences in the GenBank and EMBL data bases showed ORF1 to be 42.2% identical over 386 amino acids to CMR, the Cm resistance protein of Rhodococcus fasciens (Desomer et al., 1992), and 39.8% identical over 372 amino acids to CmlG of S. lividans (Dittrich et al., 1991). The amino termini of CMR and CmlG align optimally with Met-25 of ORF1 rather than with Met-1, and since AraJ (Reeder and Schleif, 1991) and NorA (Yoshida et al., 1990), two other hydrophobic proteins with sequence similarity to ORF1, also align at their amino termini with Met-25, the translational start codon for ORF1 is likely to be the ATG at nt 100-102. This being so, then ORF1 is a polypeptide of 412 amino acids (M(r) 41,479).

ORF1 shows greater than 60% sequence similarity over 300 amino acids to a number of antibiotic resistance proteins presumed to be integral membrane components and capable of promoting active and specific antibiotic efflux (Levy, 1992). Examples include the quinolone resistance determinant (NorA) of Staphylococcus aureus noted above, the methylenomycin resistance protein (Mmr) of the methylenomycin producer Streptomyces coelicolor (Neal and Chater, 1987), and the tetracycline resistance protein (TetL) of Bacillus stearothermophilus (McMurry et al., 1987). All such proteins probably contain 12-14 membrane-spanning alpha-helical segments that form a transmembrane channel (Paulsen and Skurray, 1993).

ORF2

Translation of ORF2 begins at either of two possible start codons: GTG at nt 1412-1414 or ATG at nt 1424-1426. The sequence 5`-GGTGA-3`, showing complementarity to the 3` end of S. lividans 16 S rRNA (DeltaG = -11.6 kcal: Tinoco et al., 1973; Bibb and Cohen, 1982) is present 4 bp (nt 1403-1407) upstream of the GTG codon, and also 8 bp (nt 1411-1415) upstream of the ATG codon. The 4-bp distance is below the range (5-12 bp) commonly observed for the separation between a ribosome-binding site and the translational start point in streptomycetes (Strohl, 1992). Beginning 26 bp upstream of the GTG codon, the sequence 5`-CACCGT-3` (nt 1381-1386) represents a possible -10 hexamer recognized by E-like RNA polymerase (Strohl, 1992). However, the region upstream of the GTG codon contains a second such sequence (5`-TACGGT-3`; nt 1400-1405). Transcription from this hexamer should initiate at the first nucleotide of the GTG codon. Such a concurrence of translational and transcriptional start sites is not uncommon in streptomycetes (Strohl, 1992).

Initiation of translation at the GTG codon would yield a polypeptide of 178 amino acids (M(r) 18,804), whereas a polypeptide initiated at the ATG codon would contain only 174 amino acids (M(r) 18,315). Although a FASTA comparison of the amino acid sequence with the GenBank and EMBL data bases revealed no significant similarities, use of the alignment program MPsrch (Sturrock and Collins, 1993) showed resemblance between the NH(2)-terminal region of the ORF2 product and predicted nucleotide-binding sites in such ATP-requiring proteins as pantothenate kinase of E. coli (Song and Jackowski, 1992) and GlnQ of B. stearothermophilus (Wu and Welker, 1991). Examination of ORF2 using the Motifs program (Genetics Computer Group Inc., version 7.3), showed the presence of the ``P-loop'' phosphate-binding motif found in many classes of adenine and guanine nucleotide-binding proteins (Saraste et al., 1990). The ORF2 sequence GGSSAGKS (aa 10-17; see Fig. 4) fits the P-loop motif consensus (A/G)XXXXGK(S/T) for an ATP/GTP binding site (Walker et al., 1982; Saraste et al., 1990), and implicates ORF2 in a process such as phosphoryl transfer. Also present in the ORF2 polypeptide is the sequence DADG (aa 57-60; see Fig. 4), which corresponds to a proposed consensus element (DXXG) for GTP/GDP-binding sites (Dever et al., 1987). The linear separation between the aspartic acid of DXXG, which interacts with nucleotide-bound Mg, and the P-loop lysine, thought to interact with the beta- and -phosphates of the bound nucleotide, conforms to the observed separation (40-80 residues) between these amino acids (Saraste et al., 1990; Mimura et al., 1991).

ORF3

Translation of ORF3 from the possible GTG start codon (nt 2266-2264; Fig. 4) would generate a polypeptide of 89 amino acids with a deduced M(r) of 9,767. A comparison of the amino acid sequence with those in GenBank and EMBL data bases revealed no significant similarities.

Identification of the Cm Resistance Determinant in the 2.4-kbp Insert

The striking sequence similarity between ORF1 and gene products associated with antibiotic resistance in other bacteria suggested a role for ORF1 in the Cm resistance of S. lividans RM4. However, the genes for CMR and CmlG confer resistance to concentrations of Cm greater than 200 µg/ml on their hosts (Dittrich et al., 1991; Desomer et al., 1992), whereas the maximal resistance to Cm conferred upon S. lividans M252 by pJV4 is 12.5 µg/ml. To determine if Cm resistance is affected by the absence of ORF2 and ORF3, a 1.4-kbp Acc651-BstEII fragment containing only ORF1 was excised from pJV7 (E. coli vector pTZ18R carrying the 2.4-kbp KpnI-SstI insert from pJV4) and subcloned in the residual pJV4 vector segment obtained by digesting pJV4 with Acc65I and EcoICRI to remove the 2.4-kbp insert. The presence of the 1.4-kbp insert in the resulting plasmid (pDC-ORF1; see Fig. 6) was verified by restriction enzyme analysis. Transformation of S. lividans M252 with pDC-ORF1 gave Cm-sensitive colonies, a result indicating that ORF1 by itself did not confer the Cm resistance phenotype of pJV4 transformants.


Figure 6: A schematic diagram of the vectors described in the text. Numbers refer to the nucleotide sequence of restriction enzyme sites in the 2.4-kbp KpnI-SstI segment of pJV4 DNA.



Evidence that resistance depended on the presence of an intact ORF2 in pJV4 was obtained by deleting a segment of DNA between two SalI sites within ORF2. The deletion plasmid was constructed in the Streptomyces-E. coli shuttle vector pHJL400. Transformation of S. lividans M252 with the vector carrying the 2.4-kbp S. venezuelae DNA insert from which the SalI-SalI fragment had been deleted yielded Cm-sensitive colonies, in contrast to the Cm-resistant transformants obtained with a control plasmid in which ORF2 was intact. Transformants with the deletion in ORF2 also differed from those with ORF2 intact in that they failed to convert Cm to 3`-phospho-CM.

Subcloning and Expression of ORF2 in S. lividans

To determine whether ORF2 alone conferred Cm resistance in S. lividans RM4, the 1.67-kbp SmaI-SmaI segment, lacking large segments of both ORF1 and ORF3 (see Fig. 6), was excised from pJV7 and cloned in the E. coli vector pUC19. The resultant plasmid (pDC1.6) was linearized with HindIII, and ligated to the Streptomyces vector pIJ6017 carrying the thiostrepton-inducible promoter tip (Murakami et al., 1989). (^2)The E. coli-Streptomyces shuttle vector (pSV1.6) so formed was used to transform S. lividans M252, and colonies were selected for Cm resistance. In bioassays these resistant transformants were inhibited by Cm concentrations above 10 µg/ml, compared with 12.5 µg/ml for RM4. When cultures were grown in GNY medium containing Cm, HPLC analysis of the culture supernatant showed that the antibiotic was converted to 3`-phospho-Cm; however, concentrations in the supernatant were only 20% of those in RM4 cultures. We were unable to measure 3`-phospho-Cm concentrations in the cells from these cultures. Since Cm resistance was observed without induction of the tip promoter, the presence of a functioning promoter upstream of ORF2 seems likely. Overall, the results indicate that phosphorylation by the ORF2 product is mainly responsible for the Cm resistance phenotype of S. lividans RM4, but the ORF1 product may also have a role.


DISCUSSION

In a previous report (Mosher et al., 1990), the presence of small quantities of metabolites derived from Cm-base in cultures of the Cm-resistant S. lividans strain RM3 supplemented with Cm was offered as evidence that a chloramphenicol amide hydrolase mediated Cm resistance in S. venezuelae. In the present study, a more exhaustive analysis of the culture broths of S. lividans RM3 and RM4 revealed a hitherto unidentified polar metabolite as the major product of Cm metabolism. Enough of the metabolite was obtained by incubating Cm with resting RM4 cells to allow its isolation, purification by C(18) reverse-phase column chromatography, and identification as the 3`-O-phosphoryl ester of Cm. That ORF2 has a role in the Cm resistance conferred by pJV4 was established by the concurrent loss of Cm kinase activity and resistance when an internal segment was deleted. We conclude that ORF2 encodes the enzyme that catalyses the phosphorylation of Cm, for which we have proposed the trivial name chloramphenicol 3`-O-phosphotransferase.

Much early work on the relationship between the structure of Cm and its antibiotic activity (summarized by Pongs, 1979) emphasized the importance of an unmodified primary alcohol at C-3`. Consistent with this, bacterial resistance to Cm is commonly mediated by enzymic acetylation of the C-3` hydroxyl group (Shaw and Leslie, 1991). The discovery that a Cm-producing streptomycete modifies the same functional group by an alternative mechanism suggests that this transformation is responsible for self-resistance. Phosphorylation is widely used to confer resistance to antibiotics, both in producing and in susceptible nonproducing organisms (Cundliffe, 1992). Nonetheless, in the more than four decades during which Cm has been used to treat infections in humans and animals, phosphorylation has not hitherto been reported as a mechanism for inactivating this antibiotic. Its presence in a Cm-producing streptomycete implies that, here at least, the origin of a resistance mechanism cannot easily be attributed to horizontal transfer of a gene conferring protection on an antibiotic producer.

Although the deduced primary structure of chloramphenicol 3`-O-phosphotransferase does not show end-to-end similarity to proteins in current data bases, it does contain localized regions of sequence similarity to a number of proteins requiring nucleotide cofactors. The presence near the NH(2) terminus of a consensus P-loop sequence similar to known ATP/GTP-binding sites is compatible with the role of chloramphenicol 3`-O-phosphotransferase in phosphoryl transfer. The P-loop motif occurs in a wide variety of proteins that, although diverse in biochemical function, have both a common nucleotide binding sequence and similar structures (Saraste et al., 1990; Schulz, 1992). Among these are the human Ha-ras p21 protein, E. coli adenylate kinase, EF-Tu and dethiobiotin synthetase (Jurnak, 1985; Pai et al., 1989, 1990; Muller and Schulz, 1992; Huang et al., 1994; Alexeev et al., 1994). The ATP-binding site is also present in the transport protein superfamily that includes the cystic fibrosis gene product (Hyde et al., 1990; Mimura et al., 1991). In many proteins of this class the polypeptide is folded into a barrel of parallel beta-sheets surrounded by alpha-helices to give a ``core structure'' (Milner-White et al., 1991). The glycine-rich region of the loop contributes to forming a giant anion hole accommodating the nucleotide triphosphate oxygen atoms.

Although three intact ORFs are present in the 2.4-kbp KpnI-SstI DNA fragment cloned in pJV4 from S. venezuelae, large segments of ORF1 and ORF3 can be deleted with only a 10-20% loss of the Cm resistance phenotype conferred on S. lividans M252 transformants by the plasmid. Cm resistance and the ability to phosphorylate Cm are retained only when ORF2 remains intact; selective disruption of ORF2 eliminates both capabilities. The conclusion that cpt is involved in the resistance conferred by pJV4 is consistent with chemical characterization of the Cm inactivation product as 3`-phospho-Cm, and sequence analysis of the deduced gene product indicated that the primary structure contains a nucleotide-binding motif. Although ORF1 contributes to the Cm resistance of S. lividans RM4, it does not have a predominant role. This is unexpected given its similarity to proteins associated with resistance to greater than 200 µg/ml Cm in other bacteria. Its lack of activity in pJV4 could be attributed to the absence of upstream regulatory sequences, but the comparable Cm resistance conferred by pJV3, in which 4.1 kbp of upstream sequence from S. venezuelae remains intact, renders this explanation unsatisfactory. A possible alternative is that ORF1 encodes an efflux protein for 3-phospho-Cm, rather than for Cm itself, and that it functions in the presence of chloramphenicol 3`-O-phosphotransferase to facilitate the export of inactivated antibiotic.


FOOTNOTES

*
This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (to L. C. V.) and the Science and Engineering Research Council of the United Kingdom through its Biotransformations Programme (to W. V. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) U09991[GenBank].

§
Current address: Dept. of Biological Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E9. rmosher@gpu.srv.ualberta.ca.

(^1)
The abbreviations used are: Cm, chloramphenicol; Cm-base, D-threo-p-nitrophenylserinol (free amine of Cm); HPLC, high performance liquid chromatography; CAT, chloramphenicol acetyltransferase; cpt, gene encoding chloramphenicol 3`-O-phosphotransferase; Delta, deletion; ORF, open reading frame; Kan, kanamycin; Amp, ampicillin; Thio, thiostrepton; kbp, kilobase pair; nt, nucleotide; bp, base pair(s).

To whom correspondence and reprint requests should be addressed: Tel.: 44-116-2523470; Fax: 44-116-2523369.

**
To whom correspondence and reprint requests should be addressed. Tel.: 902-494-2040; Fax: 902-494-3736; lvining@ac.dal.ca.

(^2)
M. J. Bibb, personal communication.


ACKNOWLEDGEMENTS

We thank Dr. D. Hooper, Chemistry Department, Dalhousie University, for the NMR spectra and Dr. P. Thibault, Institute for Marine Biosciences, National Research Council of Canada, for mass spectrometry. We are also grateful to Drs. H. I. Schrempf, Universität Osnabrück, Germany, and M. J. Bibb, John Innes Institute, Norwich, UK, for gifts of S. lividans M252 and plasmid pIJ6017, respectively.


REFERENCES

  1. Alexeev, D., Baxter, R. L., and Sawyer, L. (1994) Structure 2, 1061-1072 [Medline] [Order article via Infotrieve]
  2. Bibb, M. J., and Cohen, S. N. (1982) Mol. & Gen. Genet. 187, 265-277
  3. Bibb, M. J., Findlay, P. R., and Johnson, M. W. (1984) Gene 30, 157-166 [CrossRef][Medline] [Order article via Infotrieve]
  4. Cundliffe, E. (1992) in Secondary Metabolites: Their Function and Evolution (Chadwick, D. J., and Whelan, J., eds) pp. 199-214, Chichester, Wiley, United Kingdom
  5. Desomer, J., Vereecke, D., Crespi, M., and Van Montagu, M. (1992) Mol. Microbiol. 6, 2377-2385 [Medline] [Order article via Infotrieve]
  6. Dever, T. E., Glynias, M. J., and Merrick, W. C. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1814-1818 [Abstract]
  7. Dittrich, W., Betzler, M., and Schrempf, H. (1991) Mol. Microbiol. 5, 2789-2797 [Medline] [Order article via Infotrieve]
  8. Doran, J. L., Leskiw, B. K., Petrich, A. K., Westlake, D. W. S., and Jensen, S. E. (1990) J. Ind. Microbiol. 5, 197-206 [Medline] [Order article via Infotrieve]
  9. Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Bruton, C. J., Kieser, H. M., Lydiate, D. J., Smith, C. P., Ward, J. M., and Schrempf, H. (1985) in Genetic Manipulations of Streptomyces: A Laboratory Manual, John Innes Foundation, Norwich, UK
  10. Huang, W., Lindqvist, Y., Schneider, G., Gibson, K. J., Flint, D., and Lorimer, G. (1994) Structure 2, 407-414 [Medline] [Order article via Infotrieve]
  11. Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., and Higgins, C. F. (1990) Nature 346, 362-365 [CrossRef][Medline] [Order article via Infotrieve]
  12. Jurnak, F. (1985) Science 230, 32-36 [Medline] [Order article via Infotrieve]
  13. Larson, J. L., and Hershberger, C. L. (1986) Plasmid 15, 199-209 [Medline] [Order article via Infotrieve]
  14. Levy, S. B. (1992) Antimicrob. Agents Chemother. 36, 695-703 [Medline] [Order article via Infotrieve]
  15. Malik, V. S., and Vining, L. C. (1970) Can. J. Microbiol. 16, 173-180 [Medline] [Order article via Infotrieve]
  16. Malik, V. S., and Vining, L. C. (1972) Can. J. Microbiol. 18, 137-143 [Medline] [Order article via Infotrieve]
  17. McMurry, L. M., Park, B. H., Burdett, V., and Levy, S. B. (1987) Antimicrob. Agents Chemother. 31, 1648-1650 [Medline] [Order article via Infotrieve]
  18. Milner-White, E. J., Coggins, J. R., and Anton, I. A. (1991) J. Mol. Biol. 221, 751-754 [CrossRef][Medline] [Order article via Infotrieve]
  19. Mimura, C. S., Holbrook, S. R., and Ames, G. F.-L. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 84-88 [Abstract]
  20. Mosher, R. H. (1993) DNA Sequencing and Characterization of a Chloramphenicol Resistance Gene from Streptomyces venezuelae . Ph. D. thesis, Dalhousie University, Canada
  21. Mosher, R. H., Ranade, N. P., Schrempf, H., and Vining, L. C. (1990) J. Gen. Microbiol. 136, 293-301 [Medline] [Order article via Infotrieve]
  22. Muller, C. W., and Schulz, G. E. (1992) J. Mol. Biol. 224, 159-177 [Medline] [Order article via Infotrieve]
  23. Murakami, T., Holt, T. G., and Thompson, C. J. (1989) J. Bacteriol. 171, 1459-1466 [Medline] [Order article via Infotrieve]
  24. Nakano, H., Matsuhashi, Y., Takeuchi, T., and Umezawa, H. (1977) J. Antibiot. 30, 76-82 [Medline] [Order article via Infotrieve]
  25. Neal, R. J., and Chater, K. F. (1987) Gene (Amst.) 58, 229-241 [Medline] [Order article via Infotrieve]
  26. Pai, E. F., Kabsch, W., Krengel, U., Holmes, K. C., John, J., and Wittinghofer, A. (1989) Nature 341, 209-214 [CrossRef][Medline] [Order article via Infotrieve]
  27. Pai, E. F., Krengel, U., Petsko, G. A., Goody, R. S., Kabsch, W., and Wittinghofer, A. (1990) EMBO J. 9, 2351-2359 [Abstract]
  28. Paulsen, I. T., and Skurray, R. A. (1993) Gene (Amst.) 124, 1-11 [CrossRef][Medline] [Order article via Infotrieve]
  29. Pearson, W. R., and Lipman, D. J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2444-2448 [Abstract]
  30. Pongs, O. (1979) in Antibiotics: Mechanism of Action of Antibacterial Agents (Hahn, F. E., ed) Fifth Edition, pp. 26-42, Springer-Verlag, Berlin
  31. Reeder, T., and Schleif, R. (1991) J. Bacteriol. 173, 7765-7771 [Medline] [Order article via Infotrieve]
  32. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  33. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  34. Saraste, M., Sibbald, P. R., and Wittinghofer, A. (1990) Trends Biochem. Sci. 15, 430-434 [CrossRef][Medline] [Order article via Infotrieve]
  35. Schulz, G. E. (1992) Curr. Opin. Struct. Biol. 2, 61-67 [CrossRef]
  36. Shaw, W. V. (1983) CRC Crit. Rev. Biochem. 14, 1-46 [Medline] [Order article via Infotrieve]
  37. Shaw, W. V., and Leslie, A. G. W. (1991) Annu. Rev. Biophysics Biophys. Chem. 20, 363-386 [CrossRef][Medline] [Order article via Infotrieve]
  38. Shaw, W. V., and Hopwood, D. A. (1976) J. Gen. Microbiol. 94, 159-166 [Medline] [Order article via Infotrieve]
  39. Song, W.-J., and Jackowski, S. (1992) J. Bacteriol. 174, 6411-6417 [Abstract]
  40. Strohl, W. R. (1992) Nucleic Acids Res. 20, 961-974 [Abstract]
  41. Sturrock, S. S., and Collins, J. F. (1993) Biocomputing Unit, University of Edinburgh, UK
  42. Tinoco, I., Jr., Borer, P. N., Dengler, B., Levine, M. D., Uhlenbeck, O. C., Crothers, D. M., and Gralla, J. (1973) Nat. New Biol. 246, 40-41 [Medline] [Order article via Infotrieve]
  43. Uchiyama, H., and Weisblum, B. (1985) Gene (Amst.) 38, 103-110 [Medline] [Order article via Infotrieve]
  44. Vining, L. C., and Westlake, D. W. S. (1984) in Bio/Technology of Industrial Antibiotics (Vandamme, E. J., ed) pp. 387-409, Marcel Dekker, New York
  45. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951 [Medline] [Order article via Infotrieve]
  46. Wright, F., and Bibb, M. J. (1992) Gene (Amst.) 113, 55-65 [CrossRef][Medline] [Order article via Infotrieve]
  47. Wu, L., and Welker, N. E. (1991) J. Bacteriol. 173, 4877-4888 [Medline] [Order article via Infotrieve]
  48. Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-119 [CrossRef][Medline] [Order article via Infotrieve]
  49. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., and Konno, M. (1990) J. Bacteriol. 172, 6942-6949 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.